Compulsory licensing for expensive medicines

Esther  Van Zimmeren; Timo Minssen; Liesbet Paemen; Walter Van Dyck; Jeroen Luyten; Rosanne Janssens; Liese Barbier; Steven  Simoens; Celine Pouppez; Irina Cleemput; Imgard  Vinck

Compulsory licensing for expensive medicines

Esther Van Zimmeren, Timo Minssen, Liesbet Paemen, Walter Van Dyck, Jeroen Luyten, Rosanne Janssens, Liese Barbier, Steven Simoens, Celine Pouppez (Editor), Irina Cleemput (Editor), Imgard Vinck (Editor)

Center for Advanced Studies in Bioscience Innovation Law

Research output: Book/Report › Report › Commissioned › peer-review

Abstract

Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.

Original language	English

Place of Publication	Brussels
Publisher	Belgian Health Care Knowledge Centre (KCE).
Number of pages	200
Publication status	Published - 14 Jun 2022

Keywords

Faculty of Law
Patents
Data
compulsory licensing
expensive medicine

Access to Document

https://kce.fgov.be/en/compulsory-licensing-for-expensive-medicinesLicence: Unspecified

Cite this

Compulsory licensing for expensive medicines. / Van Zimmeren, Esther ; Minssen, Timo; Paemen, Liesbet; Van Dyck, Walter; Luyten, Jeroen; Janssens, Rosanne; Barbier, Liese; Simoens, Steven ; Pouppez, Celine (Editor); Cleemput, Irina (Editor); Vinck, Imgard (Editor).

Brussels : Belgian Health Care Knowledge Centre (KCE)., 2022. 200 p.

Research output: Book/Report › Report › Commissioned › peer-review

@book{a7537cce19a24b8bb9e8f3908a2df83f,

title = "Compulsory licensing for expensive medicines",

abstract = "Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.",

keywords = "Faculty of Law, Patents, Data, compulsory licensing, expensive medicine",

author = "{Van Zimmeren}, Esther and Timo Minssen and Liesbet Paemen and {Van Dyck}, Walter and Jeroen Luyten and Rosanne Janssens and Liese Barbier and Steven Simoens",

editor = "Celine Pouppez and Irina Cleemput and Imgard Vinck",

year = "2022",

month = jun,

day = "14",

language = "English",

publisher = "Belgian Health Care Knowledge Centre (KCE).",

}

TY - RPRT

T1 - Compulsory licensing for expensive medicines

AU - Van Zimmeren, Esther

AU - Minssen, Timo

AU - Paemen, Liesbet

AU - Van Dyck, Walter

AU - Luyten, Jeroen

AU - Janssens, Rosanne

AU - Barbier, Liese

AU - Simoens, Steven

A2 - Pouppez, Celine

A2 - Cleemput, Irina

A2 - Vinck, Imgard

PY - 2022/6/14

Y1 - 2022/6/14

N2 - Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.

AB - Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.

KW - Faculty of Law

KW - Patents

KW - Data

KW - compulsory licensing

KW - expensive medicine

M3 - Report

BT - Compulsory licensing for expensive medicines

PB - Belgian Health Care Knowledge Centre (KCE).

CY - Brussels

ER -